| Cash Flow | 2025-05-31 |
|---|---|
| Stock-based compensation | 4,830 |
| Net (loss) income | -64,037 |
| Prepaid income taxes | -1,243 |
| Prepaid expenses and other assets | -274 |
| Other liabilities | -2,600 |
| Deferred revenue | 2,348 |
| Accounts receivable | 5,644 |
| Accounts payable | 1,061 |
| Loss from disposal of assets | -23 |
| Currency translation adjustments | 28 |
| Depreciation and amortization | 6,857 |
| Deferred income taxes | -8,081 |
| Change in fair value of contingent consideration | -640 |
| Impairments | 77,221 |
| Amortization of investment discounts | -64 |
| Discharge of holdback obligation related to immunetrics acquisition | 224 |
| Net cash provided by operating activities | 12,539 |
| Proceeds from sales of investments | 995 |
| Proceeds from maturities of short-term investments | 14,017 |
| Capitalized computer software development costs | 2,115 |
| Purchase of short-term investments | 6,500 |
| Purchases of property and equipment | 449 |
| Purchase of long-term investments | 0 |
| Purchased intangibles | 368 |
| Net working capital & excess cash settlement - pro-ficiency acquisition | 227 |
| Net cash used in investing activities | 5,353 |
| Proceeds from the exercise of stock options | 323 |
| Payment of dividends | 0 |
| Payments on contracts payable | 1,576 |
| Net cash used in financing activities | -1,253 |
| Net increase in cash and cash equivalents | 16,639 |
Simulations Plus, Inc. (SLP)
Simulations Plus, Inc. (SLP)